TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
| Operating income (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $8.1B | +10.0% | −0.1% | 12.7% |
| Operating income (TTM) | $8.1B |
|---|---|
| YoY | +10.0% |
| 5-year CAGR | −0.1% |
| 10-year CAGR | 12.7% |
Operating income
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $7.7B | +5.6% |
| 2024 | $7.3B | +7.0% |
| 2023 | $6.9B | −18.3% |
| 2022 | $8.4B | −16.3% |
| 2021 | $10.0B | +28.7% |
| 2020 | $7.8B | +69.7% |
| 2019 | $4.6B | +21.4% |
| 2018 | $3.8B | +27.8% |
| 2017 | $3.0B | +20.4% |
| 2016 | $2.5B | +5.2% |
| 2015 | $2.3B | −6.7% |
| 2014 | $2.5B | +55.5% |
| 2013 | $1.6B | +8.6% |
| 2012 | $1.5B | +18.5% |
| 2011 | $1.3B | +5.3% |
| 2010 | $1.2B | +18.6% |
| 2009 | $1.0B | −18.5% |
| 2008 | $1.2B | +26.2% |
| 2007 | $974M | — |